Effects of Caffeine intake on Exhaled Nitric Oxide Test Results
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-001704
Sponsor Protocol Number: 18-001704
About this study
The purpose of this study is to determine if the ATS/ERS pre-requirements for exhaled nitric oxide testing stating no caffeine consumption two hours prior to the exhaled nitric oxide test could be shortened.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult patients age >18 years old that have a clinically ordered exhaled nitric oxide test who are current caffeinated coffee drinkers, performed by standard lab operating procedures.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Katrina Hynes, R.R.T., L.R.T. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available